{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T21:47:51Z","timestamp":1792705671999,"version":"4.5.0"},"reference-count":30,"publisher":"Frontiers Media SA","funder":[{"DOI":"10.13039\/501100002341","name":"Suomen Akatemia","doi-asserted-by":"publisher","award":["252411"],"award-info":[{"award-number":["252411"]}],"id":[{"id":"10.13039\/501100002341","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Microbiol."],"DOI":"10.3389\/fmicb.2015.01271","type":"journal-article","created":{"date-parts":[[2015,11,13]],"date-time":"2015-11-13T05:05:02Z","timestamp":1447391102000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":147,"title":["On-Demand Isolation of Bacteriophages Against Drug-Resistant Bacteria for Personalized Phage Therapy"],"prefix":"10.3389","volume":"6","author":[{"given":"Sari","family":"Mattila","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pilvi","family":"Ruotsalainen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matti","family":"Jalasvuori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2015,11,13]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"66","DOI":"10.4161\/bact.1.2.15845","article-title":"Phage treatment of human infections.","volume":"1","author":"Abedon","year":"2011","journal-title":"Bacteriophage"},{"key":"B2","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/j.burns.2003.11.010","article-title":"Aerobic bacterial isolates from burn wound infections and their antibiograms\u2013a five-year study.","volume":"30","author":"Agnihotri","year":"2004","journal-title":"Burns"},{"key":"B3","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1111\/j.1462-2920.2011.02603.x","article-title":"Global network of specific virus-host interactions in hypersaline environments.","volume":"14","author":"Atanasova","year":"2012","journal-title":"Environ. Microbiol."},{"issue":"96","key":"B4","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2013.00096","article-title":"A brief multi-disciplinary review on antimicrobial resistance in medicine and its linkage to the global environmental microbiota.","volume":"4","author":"Cantas","year":"2013","journal-title":"Front. Microbiol."},{"key":"B5","article-title":"US Centers for Disease Control and Prevention. U.S Department of Health and Human Services.","author":"CDC","year":"2013","journal-title":"Antibiotic Resistance Threats in the United States, 2013."},{"key":"B6","author":"CDC\/FDA\/NIH","year":"2011","journal-title":"A Public Health Action Plan to Combat Antimicrobial Resistance."},{"key":"B7","doi-asserted-by":"publisher","first-page":"769","DOI":"10.2217\/fmb.13.47","article-title":"Phage cocktails and the future of phage therapy.","volume":"8","author":"Chan","year":"2013","journal-title":"Future Microbiol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"31","DOI":"10.4161\/bact.1.1.14942","article-title":"Phages in nature.","volume":"1","author":"Clokie","year":"2011","journal-title":"Bacteriophage"},{"key":"B9","doi-asserted-by":"publisher","first-page":"1945","DOI":"10.1093\/jac\/dkr259","article-title":"Regulatory opportunities to encourage technology solutions to antibacterial drug resistance.","volume":"66","author":"Finch","year":"2011","journal-title":"J. Antimicrob. Chemother."},{"key":"B10","doi-asserted-by":"publisher","first-page":"E288","DOI":"10.1073\/pnas.1101595108","article-title":"Statistical structure of host-phage interactions.","volume":"108","author":"Flores","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B11","doi-asserted-by":"publisher","first-page":"2","DOI":"10.2174\/138920110790725311","article-title":"Phage choice, isolation, and preparation for phage therapy.","volume":"11","author":"Gill","year":"2010","journal-title":"Curr. Pharm. Biotechnol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"2192","DOI":"10.1073\/pnas.96.5.2192","article-title":"Evolutionary relationships among diverse bacteriophages and prophages: all the world\u2019s a phage.","volume":"96","author":"Hendrix","year":"1999","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B13","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/S0065-2164(10)70007-1","article-title":"Bacteriophage host range and bacterial resistance.","volume":"70","author":"Hyman","year":"2010","journal-title":"Adv. Appl. Microbiol."},{"issue":"238","key":"B14","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2012.00238","article-title":"Phage therapy: concept to cure.","volume":"3","author":"Keen","year":"2012","journal-title":"Front. Microbiol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"31","DOI":"10.4161\/bbug.2.1.13657","article-title":"Development of a broad-host-range phage cocktail for biocontrol.","volume":"2","author":"Kelly","year":"2011","journal-title":"Bioeng. Bugs"},{"key":"B16","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1038\/nrmicro2315","article-title":"Bacteriophage resistance mechanisms.","volume":"8","author":"Labrie","year":"2010","journal-title":"Nat. Rev. Microbiol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1038\/nature14098","article-title":"A new antibiotic kills pathogens without detectable resistance.","volume":"517","author":"Ling","year":"2015","journal-title":"Nature"},{"key":"B18","article-title":"The first step to bacteriophage therapy \u2013 how to choose the correct phage","author":"Lobocka","year":"2014","journal-title":"Phage Therapy: Current Research and Applications"},{"key":"B19","doi-asserted-by":"publisher","first-page":"111","DOI":"10.4161\/bact.1.2.14590","article-title":"Pros and cons of phage therapy.","volume":"1","author":"Loc-Carrillo","year":"2011","journal-title":"Bacteriophage"},{"key":"B20","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1079\/9781845939847.0185","article-title":"Phage therapy of wounds and related purulent infections","author":"Loc-Carrillo","year":"2012","journal-title":"Bacteriophages in Health and Disease"},{"key":"B21","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1016\/j.mib.2011.07.028","article-title":"The next generation of bacteriophage therapy.","volume":"14","author":"Lu","year":"2011","journal-title":"Curr. Opin. Microbiol."},{"issue":"e4944","key":"B22","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0004944","article-title":"Quality-controlled small-scale production of a well-defined bacteriophage cocktail for use in human clinical trials.","volume":"4","author":"Merabishvili","year":"2009","journal-title":"PLoS ONE"},{"issue":"e24219","key":"B23","doi-asserted-by":"publisher","DOI":"10.4161\/bact.24219","article-title":"Phage therapy: should bacterial resistance to phages be a concern, even in the long run?","volume":"3","author":"\u00d6rm\u00e4l\u00e4","year":"2013","journal-title":"Bacteriophage"},{"key":"B24","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1007\/s11095-010-0313-5","article-title":"The phage therapy paradigm: pr\u00eat-\u00e0-porter or sur-mesure?","volume":"28","author":"Pirnay","year":"2011","journal-title":"Pharm. Res."},{"key":"B25","author":"Sambrook","year":"1989","journal-title":"Molecular Cloning: A Laboratory Manual"},{"key":"B26","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1007\/s10529-007-9346-1","article-title":"Biotechnological challenges of phage therapy.","volume":"29","author":"Skurnik","year":"2007","journal-title":"Biotechnol. Lett."},{"key":"B27","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1016\/j.mib.2011.07.005","article-title":"Antibiotics and the resistant microbiome.","volume":"14","author":"Sommer","year":"2011","journal-title":"Curr. Opin. Microbiol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1128\/AAC.45.3.649-659.2001","article-title":"Bacteriophage therapy.","volume":"45","author":"Sulakvelidze","year":"2001","journal-title":"Antimicrob. Agents Chemother."},{"key":"B29","author":"World Health Organization [WHO]","year":"2014","journal-title":"Antimicrobial Resistance: Global Report on Surveillance."},{"key":"B30","first-page":"64","article-title":"A study of the therapeutic effect of bacteriophage agents in a complex treatment of suppurative surgical diseases.","volume":"12","author":"Zhukov-Verezhnikov","year":"1978","journal-title":"Sov. Med."}],"container-title":["Frontiers in Microbiology"],"original-title":[],"deposited":{"date-parts":[[2017,6,23]],"date-time":"2017-06-23T19:35:49Z","timestamp":1498246549000},"score":1,"resource":{"primary":{"URL":"http:\/\/journal.frontiersin.org\/Article\/10.3389\/fmicb.2015.01271\/abstract"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,11,13]]},"references-count":30,"URL":"https:\/\/doi.org\/10.3389\/fmicb.2015.01271","relation":{},"ISSN":["1664-302X"],"issn-type":[{"value":"1664-302X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,11,13]]}}}